Top Markets
Coin of the day
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc.

KYTX
Hisse Senetlerindeki Sıralama #13175
Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Hisse Fiyatı
$8.46
Son senkronizasyon: 2026-08-28
Piyasa Değeri
$514.33M
Değişim (1 gün)
-2.08%
Değişim (1 yıl)
128.03%
Ülke
US
Ticaret Kyverna Therapeutics, Inc. (KYTX)

Kategori

Kyverna Therapeutics, Inc. (KYTX) için hisse bölünme geçmişi
Kyverna Therapeutics, Inc. hissesi (sembol: KYTX) toplamda 0 hisse bölünmesi yaşamıştır.
En son hisse bölünmesi Aug 31, 2026 tarihinde gerçekleşmiştir.
Aug 31, 2026 tarihinden önce alınan bir KYTX hissesi bugün 0 KYTX hissesine eşdeğerdir.
Hisse bölünme listesi
Yıl Bölünme Çarpan Kümülatif Çarpan
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için hisse bölünmeleri
Şirket Hisse bölünme sayısı Kümülatif Çarpan Ülke
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH